PLSE - パルス・バイオサイエンシズ (Pulse Biosciences Inc) パルス・バイオサイエンシズ

 PLSEのチャート


 PLSEの企業情報

symbol PLSE
会社名 Pulse Biosciences Inc (パルス・バイオサイエンシズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 パルス・バイオサイエンス(Pulse Biosciences Inc.)(旧名:Electroblate Inc.)はナノパルス電気信号法(NPES)と呼ばれるプラットフォーム技術を使用する開発段階医療機器会社である。NPESはナノ秒パルス電場を利用して細胞シグナリング及び組織内細胞経路の活性化を誘導する局所的・ドラッグフリー技術である。NPESは各種皮膚科と美容分野での治療法を提供する。同社は心臓アブレーション、肺疾患、バレット食道、甲状腺結節、耳、鼻と咽頭(ENT)乳頭腫等の低侵襲性治療法を提供する。同社はPulseTxシステム(PulseTx)として識別されるNPES治療のシステムを開発する。PulseTxシステムは、可変パルス発生器とその計画された一連の電極を介してNPESパルスを送ります。 PulseTxシステムパルスは電極で組織に直接応用され、細胞と細胞小器官膜に一時的ナノメートル孔を生成する。  パルス・バイオサイエンシズは米国の医療装置メ―カ―。主に「ナノ・パルス・エレクトロ・シグナリング(NPES)」システムを開発する。NPESのパラメ―タを調整することにより、分泌やアポト―シス、壊死を含む細胞反応を誘発することが可能。同社の「パルスTX TM」システムのあるクリニックではNPSEを利用できる。本社はカリフォルニア州。   Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
本社所在地 3957 Point Eden Way Hayward CA 94545 USA
代表者氏名
代表者役職名
電話番号 +1 510-906-4600
設立年月日 41760
市場名 NASDAQ Small Cap
ipoyear 2016年
従業員数 33人
url www.pulsebiosciences.com
nasdaq_url https://www.nasdaq.com/symbol/plse
adr_tso
EBITDA EBITDA(百万ドル) -33.11900
終値(lastsale) 12.7808
時価総額(marketcap) 215821010.9568
時価総額 時価総額(百万ドル) 163.45980
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 135.96080
当期純利益 当期純利益(百万ドル) -34.02000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Pulse Biosciences Inc revenues was not reported. Net loss increased 90% to $17.8M. Higher net loss reflects General and administrative - Balancing v increase from $2.5M to $5.5M (expense) Stock-based Compensation in SGA increase from $2.5M to $5.1M (expense) Research and development - Balancing val increase of 56% to $5.6M (expense).

 PLSEのテクニカル分析


 PLSEのニュース

   The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement  2020/02/25 13:28:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.
   The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering  2020/02/14 13:23:03 Benzinga Feeds
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL ) AtriCure Inc. (NASDAQ: ATRC ) Beam Therapeutics Inc (NASDAQ: BEAM ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fortress Biotech (NASDAQ: FBIO ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Masimo Corporation (NASDAQ: MASI ) NeoGenomics, Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Recro Pharma Inc (NASDAQ: REPH ) ResMed Inc. (NYSE: RMD ) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Thursday) Syneos Health Inc (NASDAQ: SYNH ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Taro Pharmaceutical Industries Ltd. (NYSE: TARO ) West Pharmaceutical Services Inc.
   Pulse Biosciences Updates on Regulatory Progress  2019/12/18 14:00:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--PULSE BIOSCIENCES UPDATES ON REGULATORY PROGRESS
   Pulse Biosciences Announces Transition of Chief Financial Officer  2019/11/07 20:44:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--PULSE BIOSCIENCES ANNOUNCES TRANSITION OF CHIEF FINANCIAL OFFICER Company announces the appointment of Sandra Gardiner as Chief Financial Officer
   Pulse Biosciences to Report Third Quarter 2019 Operational Highlights and Financial Results  2019/10/31 17:51:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), will report third quarter 2019 operational highlights and financial results on Thursday, November 7, 2019.
   The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement  2020/02/25 13:28:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.
   The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering  2020/02/14 13:23:03 Benzinga Feeds
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL ) AtriCure Inc. (NASDAQ: ATRC ) Beam Therapeutics Inc (NASDAQ: BEAM ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fortress Biotech (NASDAQ: FBIO ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Masimo Corporation (NASDAQ: MASI ) NeoGenomics, Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Recro Pharma Inc (NASDAQ: REPH ) ResMed Inc. (NYSE: RMD ) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Thursday) Syneos Health Inc (NASDAQ: SYNH ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Taro Pharmaceutical Industries Ltd. (NYSE: TARO ) West Pharmaceutical Services Inc.
   Pulse Biosciences Updates on Regulatory Progress  2019/12/18 14:00:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--PULSE BIOSCIENCES UPDATES ON REGULATORY PROGRESS
   Pulse Biosciences Announces Transition of Chief Financial Officer  2019/11/07 20:44:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--PULSE BIOSCIENCES ANNOUNCES TRANSITION OF CHIEF FINANCIAL OFFICER Company announces the appointment of Sandra Gardiner as Chief Financial Officer
   Pulse Biosciences to Report Third Quarter 2019 Operational Highlights and Financial Results  2019/10/31 17:51:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), will report third quarter 2019 operational highlights and financial results on Thursday, November 7, 2019.
   The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement  2020/02/25 13:28:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.
   The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering  2020/02/14 13:23:03 Benzinga Feeds
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL ) AtriCure Inc. (NASDAQ: ATRC ) Beam Therapeutics Inc (NASDAQ: BEAM ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fortress Biotech (NASDAQ: FBIO ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Masimo Corporation (NASDAQ: MASI ) NeoGenomics, Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Recro Pharma Inc (NASDAQ: REPH ) ResMed Inc. (NYSE: RMD ) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Thursday) Syneos Health Inc (NASDAQ: SYNH ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Taro Pharmaceutical Industries Ltd. (NYSE: TARO ) West Pharmaceutical Services Inc.
   Pulse Biosciences Updates on Regulatory Progress  2019/12/18 14:00:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--PULSE BIOSCIENCES UPDATES ON REGULATORY PROGRESS
   Pulse Biosciences Announces Transition of Chief Financial Officer  2019/11/07 20:44:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--PULSE BIOSCIENCES ANNOUNCES TRANSITION OF CHIEF FINANCIAL OFFICER Company announces the appointment of Sandra Gardiner as Chief Financial Officer
   Pulse Biosciences to Report Third Quarter 2019 Operational Highlights and Financial Results  2019/10/31 17:51:00 Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), will report third quarter 2019 operational highlights and financial results on Thursday, November 7, 2019.

 関連キーワード  (先端医療機器_テクノロジ― 米国株 パルス・バイオサイエンシズ PLSE Pulse Biosciences Inc)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)